- Home
- CDXS vs EMF Comparison
CDXS vs EMF Comparison
Compare CDXS & EMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- EMF
- Stock Information
- Founded
- CDXS 2002
- EMF 1987
- Country
- CDXS United States
- EMF United States
- Employees
- CDXS N/A
- EMF N/A
- Industry
- CDXS Major Chemicals
- EMF Finance/Investors Services
- Sector
- CDXS Industrials
- EMF Finance
- Exchange
- CDXS Nasdaq
- EMF Nasdaq
- Market Cap
- CDXS 216.6M
- EMF 219.3M
- IPO Year
- CDXS 2010
- EMF N/A
- Fundamental
- Price
- CDXS $2.65
- EMF $16.79
- Analyst Decision
- CDXS Buy
- EMF
- Analyst Count
- CDXS 2
- EMF 0
- Target Price
- CDXS $11.00
- EMF N/A
- AVG Volume (30 Days)
- CDXS 542.5K
- EMF 29.3K
- Earning Date
- CDXS 10-30-2025
- EMF 01-01-0001
- Dividend Yield
- CDXS N/A
- EMF 6.16%
- EPS Growth
- CDXS N/A
- EMF N/A
- EPS
- CDXS N/A
- EMF N/A
- Revenue
- CDXS $57,164,000.00
- EMF N/A
- Revenue This Year
- CDXS $12.88
- EMF N/A
- Revenue Next Year
- CDXS $21.64
- EMF N/A
- P/E Ratio
- CDXS N/A
- EMF N/A
- Revenue Growth
- CDXS N/A
- EMF N/A
- 52 Week Low
- CDXS $1.90
- EMF $10.58
- 52 Week High
- CDXS $6.08
- EMF $12.67
- Technical
- Relative Strength Index (RSI)
- CDXS 55.26
- EMF 56.77
- Support Level
- CDXS $2.46
- EMF $16.42
- Resistance Level
- CDXS $2.76
- EMF $16.95
- Average True Range (ATR)
- CDXS 0.16
- EMF 0.38
- MACD
- CDXS 0.02
- EMF -0.07
- Stochastic Oscillator
- CDXS 50.97
- EMF 58.91
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.